Use cases
Use cases
Knowledge Graphs
Build better knowledge graphs with millions of novel high quality cause-and-effect relationships and contextual data
MoA & Explainability
Novel evidence to explain diseases and hypothesise treatment approaches
Biomarker Selection
Identify novel pharmacodynamic biomarkers from > 40 million documents
Target Selection
Infer drug-target-disease cause-and-effect relationships to ID novel targets and validate existing hypotheses
Indication Expansion
Use data annotations to identify diseases directly connected to a target based on well-established literature evidence
Knowledge Reviews
Systematically retrieve all relevant information to support go/no-go decisions
Solutions
Solutions
Data scientists
The most novel knowledge graph of rich, unique data
Biologists
Novel targets and never-before-seen biological research evidence
Information Managers
The forefront of federated architecture and GenAI
Company
Resources
Resources
News
Insights and blog posts
Events
Upcoming conferences
Downloads
Datasheets and other resources
Webinars
Live events and recordings
Knowledge Graphs in Drug Discovery
Virtual conference series
Galactic Web login
Request demo
Galactic Web login
Request demo
News
PharmaTimes Magazine Reflections and predictions 2024 and 2025
PharmaTimes Magazine Reflections and predictions 2024 and 2025
Biorelate Ltd. CEO and Founder Daniel Jamieson
December 13, 2024
•
5 min read
Share this post
Biorelate News
Latest News
Discover new insights and updates for data science in biopharma
View all
Making AI Work for Drug Discovery: A Joined-up Approach
CSO Ben Sidders speaks with the Journal for Clinical Studies
PharmaTimes Magazine Reflections and predictions 2024 and 2025
Biorelate Ltd. CEO and Founder Daniel Jamieson is interviewed alongside other leading pharma thinkers in the PharmaTimes Media Ltd front cover story on reflections and prediction in Pharma
Revolutionising Life Sciences: An Insightful Conversation with Dr. Ben Sidders
In a fascinating episode of the "Life Science Success" podcast, Dr. Ben Sidders, Chief Science Officer at Biorelate, takes center stage. Host Don Davis, PhD, and MBA, engages in an enlightening conversation with Ben, who shares his journey, insights, and the groundbreaking innovations at Biorelate that promise to reshape the life sciences industry.
View all
